Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve

NCT02679261 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Bicuspid Aortic Valve

Interventions

DRUG: Atorvastatin
DRUG: Placebo

Sponsor

Hospital Universitari Vall d'Hebron Research Institute